LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology and Bixink Therapeutics have signed a license agreement in which Bixink will commercialize Puma’s drug NERLYNX in South Korea.
News Ticker
- [ September 28, 2023 ] Supervisor, Quality Control Analytical – ImmPACT Bio – West Hills, CA Los Angeles Biotech Jobs
- [ September 27, 2023 ] Associate Scientist – Veterinary Technician (Comparative Medicine) – Amgen – Thousand Oaks, CA Los Angeles Biotech Jobs
- [ September 27, 2023 ] Senior Scientist Medicinal Chemistry – Amgen – Thousand Oaks, CA Los Angeles Biotech Jobs
- [ September 27, 2023 ] Cytopreparatory Technician – Cytology Laboratory – City of Hope – Irvine, CA Los Angeles Biotech Jobs
- [ September 27, 2023 ] Amgen readies PhIII trial for first Opdivo biosimilar, with launch unlikely before 2028 Los Angeles Biotech News
Copyright © 2023 Biotech Networks, LLC
